EU approves LEO Pharma’s psoriasis biologic

20th July 2017 Uncategorised 0

A new treatment option has been approved in the European Union for patients with psoriasis, paving the way for access to a novel approach for those with moderate-to-severe forms of the disease who are candidates for systemic therapy.

More: EU approves LEO Pharma’s psoriasis biologic
Source: News